Efficacy and safety of HLX10, a novel anti-PD-1 antibody, in patients with previously treated unresectable or metastatic microsatellite instability-high or mismatch repair-deficient solid tumors: A single-arm, multicenter, phase 2 study.
文献类型：期刊论文
| 作者 | Qin, Shukui; Li, Jin; Zhong, Haijun; Jin, Chuan; Chen, Lili; Yuan, Xianglin; Fan, Qingxia; Chen, Kehe; Cao, Peiguo; Xiao, Jianjun |
| 刊名 | JOURNAL OF CLINICAL ONCOLOGY
 |
| 出版日期 | 2021-05-20 |
| 卷号 | 39 |
| ISSN号 | 0732-183X |
| DOI | 10.1200/JCO.2021.39.15_suppl.2566 |
| 资助项目 | Shanghai Henlius Biotech, Inc |
| WOS研究方向 | Oncology |
| 语种 | 英语 |
| 出版者 | LIPPINCOTT WILLIAMS & WILKINS |
| WOS记录号 | WOS:000708120601087 |
| 资助机构 | Shanghai Henlius Biotech, Inc |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/126586]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 作者单位 | 1.Cent South Univ, Xiangya Hosp 3, Changsha, Peoples R China 2.Zhongshan City Peoples Hosp, Zhongshan, Peoples R China 3.Nanjing Bayi Hosp, Chinese Peoples Liberat Army Canc Ctr, Nanjing, Peoples R China 4.Shanghai East Hosp, Shanghai, Peoples R China 5.Univ Chinese Acad Sci, Dept Med Oncol, Zhejiang Canc Hosp, Inst Canc & Basic Med,Chinese Acad Sci,Canc Hosp, Hangzhou, Peoples R China 6.Guangzhou Med Univ, Affiliated Canc Hosp, Guangzhou, Peoples R China 7.Taizhou First Peoples Hosp, Taizhou, Peoples R China 8.Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan, Hubei, Peoples R China 9.Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China 10.Peoples Hosp Guangxi Zhuang Autonomous Reg, Nanning, Peoples R China |
| 推荐引用方式 GB/T 7714 | Qin, Shukui,Li, Jin,Zhong, Haijun,et al. Efficacy and safety of HLX10, a novel anti-PD-1 antibody, in patients with previously treated unresectable or metastatic microsatellite instability-high or mismatch repair-deficient solid tumors: A single-arm, multicenter, phase 2 study.[J]. JOURNAL OF CLINICAL ONCOLOGY,2021,39. |
| APA | Qin, Shukui.,Li, Jin.,Zhong, Haijun.,Jin, Chuan.,Chen, Lili.,...&Wang, Qingyu.(2021).Efficacy and safety of HLX10, a novel anti-PD-1 antibody, in patients with previously treated unresectable or metastatic microsatellite instability-high or mismatch repair-deficient solid tumors: A single-arm, multicenter, phase 2 study..JOURNAL OF CLINICAL ONCOLOGY,39. |
| MLA | Qin, Shukui,et al."Efficacy and safety of HLX10, a novel anti-PD-1 antibody, in patients with previously treated unresectable or metastatic microsatellite instability-high or mismatch repair-deficient solid tumors: A single-arm, multicenter, phase 2 study.".JOURNAL OF CLINICAL ONCOLOGY 39(2021). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。